Medical
The companies featured on PressReleaseFinder are active in several industries.
5 Mar 2008
Wolfgang Babel to head Belden EMEA
Belden has announced the appointment of Wolfgang Babel as Vice President, Operations, and President of Belden Europe, Middle East and Africa (EMEA). Dr. Babel joined Belden in October 2007 as Managing Director of Belden Automation, comprising Hirschmann and Lumberg Automation. Dr. Babel served as Managing Director of Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH & Co., KG, in Gerlingen, Germany, designers and manufacturers of measurement equipment and process instrumentation. Previously he held progressively responsible positions with Diehl GmbH & Co. KG, an electronics and munitions company. He has a Doctor of Engineering degree in information technology from the Friedrich-Alexander-Universität in Nuremberg and a Ph.D. in System Theory Mathematics from Columbia Pacific University, San Francisco.
29 Feb 2008
DSM expands biomedical portfolio
DSM Biomedical today announced the start of a development program of polyester based Thermoplastic Elastomers (TPE) for use in medical devices. In the coming years DSM Biomedical will work together with medical device companies to develop tailored TPE material grades. These grades will be specifically aimed at making orthopedic devices perform better or, alternatively, at enabling the development of novel products and therapies.
London, February 7, 2008: China, already acknowledged as the fastest growing trading nation in the world, continues to look outward for project partners to aid its further economic expansion and share in its rewards. The variety and scale of China’s current industrial needs offer major business opportunities for companies seriously seeking entry into this huge market. Importantly, the nature of many of the projects now being tended have the potential to provide stable platforms on which to build sustainable future growth in China for partnering companies.
SAN MATEO, Calif. – Oct. 31, 2007 – At the BioInterface 2007 Workshop and Symposium, Aylvin Dias, Ph.D, R&D program manager for DSM Biomedical, will chair a double session on antimicrobial surfaces with emphasis on biofilms, biofouling and biocidal approaches. This session will be attended by a number of industrial and academic opinion leaders to discuss the latest developments on and challenges to medical device associated infections. During the session, Dr. Dias will introduce ComfortCoat™, DSM’s new coating that addresses catheter associated urinary tract infections (CAUTI). 
DSM today announced the start of an initiative to enter the market of ultra high molecular weight polyethylene (UHMWPE) for use in Total Joint Arthroplasty and other medical devices. In the upcoming years DSM Biomedical will make significant investments in a research and development program focused on UHMWPE-grades with optimized material properties, specifically aimed at currently unmet clinical needs in this orthopedic segment. This strategic material development links on to DSM’s activities in the Emerging Business Area of Biomedical Materials, which is an important element of DSM’s strategy Vision 2010 – Building on Strengths. 
URMOND (NL), 13 September, 2007 – DSM Dyneema today announced that Dyneema Purity®, its high-performance specialty polyethylene fiber developed specifically for medical applications, has been shown to promote better tissue formation than traditional polyester in orthopedic suture applications. In independent testing by NAMSA’s Biomatech Lab, braids made of Dyneema Purity® exhibited enhanced fibro-connective tissue formation as well as reduced irritation and lower inflammation compared to polyester. Coupled with the exceptional mechanical performance of Dyneema Purity®, the world’s strongest fiber, these results make this ultra high molecular weight polyethylene (UHMWPE) an excellent alternative to polyester. 